Irritable Bowel Syndrome Characterized by Constipation Terminated Phase 4 Trials for Linaclotide (DB08890)

IndicationStatusPhase
DBCOND0044250 (Irritable Bowel Syndrome Characterized by Constipation)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02837783A Study of the Effect of Linaclotide on Abdominal Girth in Participants With IBS-CTreatment